300363 Porton Pharma Solutions
- 19.78
- +2.35+13.48%
Porton Pharma Solutions News
Boteng Co., Ltd.: Announcement on the Change of Sponsor Representative
Boteng Co., Ltd.: Investor Relations Activity Record Form for November 28, 2024
Boteng Co., Ltd.: Announcement on participating in the 2024 Online Investor Group Reception Day event for listed companies under the jurisdiction of Chongqing
Boteng Co., Ltd.: Investor Relations Activity Record Form for November 19, 2024
Boteng Co., Ltd.: Investor Relations Activity Record Form for October 25, 2024
Boteng Co., Ltd.: Announcement of Resolutions of the 20th Interim Meeting of the Fifth Board of Supervisors
Boteng shares: 2024 third quarter report
Boteng Co., Ltd.: Announcement on providing guarantees for wholly-owned subsidiaries to apply for comprehensive credit from banks
Boteng Co., Ltd.: Announcement of Resolutions of the 28th Interim Meeting of the Fifth Board of Directors
Boteng Co., Ltd.: Announcement on the completion of industrial and commercial change registration for wholly-owned subsidiaries
Boteng Co., Ltd.: Announcement on the completion of industrial and commercial change registration for wholly-owned subsidiaries
Boteng Co., Ltd.: Announcement on the actual controller\'s partial share pledge and release of the pledge
Boteng Co., Ltd.: Announcement on the completion of the plan to increase the shareholding of senior management
Boteng Co., Ltd.: Attached to the Investor Relations Activity Record Form for August 28, 2024
Boteng Co., Ltd.: Investor Relations Activity Record Form for August 28, 2024
Boteng Co., Ltd.: Announcement on providing guarantees for wholly-owned subsidiaries to apply for comprehensive credit from banks
Boteng Co., Ltd.: General Manager Work Rules (August 2024)
Boteng Co., Ltd.: Announcement on changes in accounting policies
Boteng shares: 2024 semi-annual report
Boteng Co., Ltd.: Public Opinion Management System (August 2024)
No Data
